Bioactivity:

Pembrolizumab is a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2 to bind to other members of the HER family.

CAS nr:

1374853-91-4

Purity:

98%

Molecular Weight:

149000

SMILES:

Formula:

Pathway:

Apoptosis,Immunology/Inflammation,Cell Cycle/Checkpoint

Target:

PD-1/PD-L1,PD-1/PD-L1,PD-1/PD-L1